Shenqi Fuzheng injection
Specifically for Lung Cancer
0 up • 0 down
Why it works for Lung Cancer:
What it is. SFI is a sterile IV Traditional Chinese Medicine (TCM) extract of Astragalus membranaceus (Huangqi) and Codonopsis pilosula (Dangshen), used as an adjunct to standard chemotherapy—not a standalone cancer drug. Cancer.gov
Proposed mechanisms (adjunctive):
- Immunomodulation: meta-analyses report improved T-cell subsets (e.g., higher CD4+/CD8+ ratio) and NK-cell activity when SFI is added to chemotherapy. PLOS
- Chemoprotection/less myelosuppression & GI toxicity: pooled analyses show reduced rates of hematologic suppression and gastrointestinal side-effects alongside better quality of life. Frontiers
- Possible tumour-microenvironment effects: preclinical/early translational work suggests metabolic and immune-microenvironment modulation (hypothesis-generating, not definitive). ScienceDirect
How to use for Lung Cancer:
Indication (label in China): adjuvant therapy in patients with lung-/stomach-cancer who have TCM “qi deficiency” symptoms. Route: IV drip. Common dosing on manufacturer label: 250 mL once daily for 21 days, starting 3 days before chemotherapy and ending in sync with chemotherapy. en.livzon.com.cn
Cycle length recommended by a recent meta-analysis (evidence-driven suggestion): 15–28 days per chemo cycle appeared associated with the most benefit in pooled analyses. (This is not a global guideline—use local prescribing info.) Frontiers
Scientific Evidence for Lung Cancer:
Most data are Chinese RCTs with variable quality; outcomes tend to be short-term response/quality-of-life/toxicity, with limited survival data.
2023 Frontiers systematic review & meta-analysis (44 RCTs; ~3,460–3,475 patients) in advanced NSCLC, SFI + platinum-based chemo vs chemo alone:
- Objective response rate (ORR): RR 1.27 (95% CI 1.18–1.37)
- Disease control rate (DCR): RR 1.12 (95% CI 1.08–1.15)
- Quality of life improvement: RR 1.41 (95% CI 1.31–1.52)
- Lower myelosuppression and GI reactions vs chemo alone. Authors note study heterogeneity and generally modest methodological quality; call for high-quality multicenter RCTs. Frontiers
2016 PLOS ONE meta-analysis (advanced NSCLC): SFI + chemo improved immune indices (e.g., CD3+, CD4+/CD8+, NK cells) and short-term efficacy endpoints vs chemo alone; authors similarly caution about study quality. PLOS
Broader cancer settings (context): Overviews/meta-analyses in other tumours also suggest reduced chemo toxicity and immune support, but quality limitations persist—helpful context, not lung-specific standards. BioMed Central
Specific Warnings for Lung Cancer:
Manufacturer safety information (example label):
- Common/occasional reactions: low-grade fever, stomatitis, sleepiness; occasionally rash, infusion-site pain, chills/fever, vomiting, chest discomfort, palpitations.
- Contraindication (label TCM wording): states contraindicated in patients with “endogenous heat” per TCM description.
- Administration: IV drip only; prescription-only; store protected from light. en.livzon.com.cn
Allergic/hypersensitivity risk:
- Post-marketing surveillance (30,026 cases) recorded 51 ADRs (1 serious) with SFI; although the rate is low, immediate hypersensitivity has been reported with various TCM injections (including astragalus/codonopsis preparations). SFI should be given in medical settings with resuscitation capability. Europe PMC
Where it should be used: Chinese clinical principles emphasize that TCM injections should be used in healthcare institutions by prescription only with pharmacovigilance monitoring. bookcafe.yuntsg.com
Regulatory/guideline context: Major international lung-cancer guidelines (ESMO/NCCN) do not include SFI as a recommended therapy; its use is largely regional. Discuss carefully to avoid interactions/overlap with modern targeted/immunotherapy regimens. Annals of Oncology
General Information (All Ailments)
What It Is
Shenqi Fuzheng Injection (SQFZ) is a traditional Chinese medicine (TCM)-based injectable formulation that has been widely used as an adjunct therapy in cancer treatment and immune support. It is derived primarily from two medicinal herbs: Astragalus membranaceus (Huang Qi) and Codonopsis pilosula (Dang Shen). Both herbs are classic tonics in TCM known for their roles in strengthening Qi (vital energy), improving resilience, and restoring balance to the body’s internal systems.
The formulation was developed to support patients undergoing chemotherapy, radiotherapy, or suffering from chronic illnesses where immune function and vitality are compromised. It is approved and used in China as part of integrative oncology care and immune modulation therapy.
How It Works
Shenqi Fuzheng Injection exerts its effects through multi-target and multi-system mechanisms that combine immunomodulatory, anti-inflammatory, and protective functions. Its actions can be understood on both traditional Chinese medicine and modern biomedical levels:
TCM Mechanism:
- In TCM theory, SQFZ works by tonifying Qi and strengthening the body’s resistance (“Fuzheng”), helping the patient better tolerate or recover from aggressive treatments like chemotherapy (“Quxie” — eliminating pathogenic factors). This balance is believed to enhance the body’s overall capacity for self-healing and adaptation.
Biomedical Mechanisms:
- Immune modulation: SQFZ enhances the activity of T lymphocytes, macrophages, and natural killer (NK) cells. It increases cytokine production (such as IL-2 and IFN-γ), improving cellular immunity.
- Protection from treatment toxicity: Studies suggest it helps reduce chemotherapy-induced bone marrow suppression, mitigating leukopenia and fatigue.
- Antioxidant and anti-inflammatory effects: The bioactive compounds reduce oxidative stress and inflammatory responses associated with cancer and chronic disease.
- Tumor microenvironment regulation: Evidence indicates SQFZ may help inhibit tumor growth indirectly by strengthening host immune surveillance and improving systemic function.
Why It’s Important
Shenqi Fuzheng Injection holds significance in integrative medicine, particularly in oncology and chronic disease management, for several reasons:
- Adjunctive Cancer Therapy: It is often prescribed alongside chemotherapy or radiotherapy to enhance therapeutic efficacy while reducing adverse effects such as fatigue, nausea, immune suppression, and appetite loss.
- Improved Quality of Life: Patients receiving SQFZ often report better physical endurance, appetite, and emotional well-being.
- Bridging TCM and Modern Medicine: It exemplifies the integration of traditional herbal wisdom with contemporary pharmacology, offering a holistic yet evidence-based therapeutic option.
- Immune Restoration: Its immune-supportive role makes it relevant not only in cancer care but also in conditions of immune deficiency, chronic infections, and recovery from major illnesses.
Considerations
While Shenqi Fuzheng Injection is generally considered safe under medical supervision, several important considerations should be kept in mind:
- Clinical Guidance: It should be administered by qualified healthcare professionals familiar with both TCM and modern clinical protocols. The dosage and duration vary depending on the patient’s condition and concurrent treatments.
- Adverse Effects: Adverse reactions are rare but may include allergic responses, skin rash, mild fever, or local irritation at the injection site. Patients with known allergies to herbal preparations should exercise caution.
- Drug Interactions: Although often used with chemotherapy drugs, careful monitoring is necessary to ensure no pharmacokinetic or pharmacodynamic interactions occur. Its immune-stimulating effects might, in theory, influence the efficacy of immunosuppressive therapies.
- Quality Control: Because it is an herbal injection, product quality, manufacturing standards, and batch consistency are critical. Only clinically approved, standardized preparations should be used.
- Regulatory Status: SQFZ is approved and widely used in China but not yet authorized by regulatory agencies like the FDA or EMA for use in Western countries. Therefore, access and legal use may be restricted outside of Asia.
Helps with these conditions
Shenqi Fuzheng injection is most effective for general wellness support with emerging research . The effectiveness varies by condition based on clinical evidence and user experiences.
Detailed Information by Condition
Lung Cancer
What it is. SFI is a sterile IV Traditional Chinese Medicine (TCM) extract of Astragalus membranaceus (Huangqi) and Codonopsis pilosula (Dangshen), us...
Community Discussion
Share results, tips, and questions about Shenqi Fuzheng injection.
Loading discussion...
No comments yet. Be the first to start the conversation!
Discussion for Lung Cancer
Talk specifically about using Shenqi Fuzheng injection for Lung Cancer.
Loading discussion...
No comments yet. Be the first to start the conversation!
Remedy Statistics
Helps With These Conditions
Recommended Products
No recommended products added yet.